How Agentic AI Shortens Drug Development and ...

Instacart has 1.6 billion lifetime grocery orders—and is now using that data flywheel to digitize the physical store itself. In this episode, David McIntosh, Chief Connected Stores Officer at Instacart, explains how the Caper Cart—powered by an NVIDIA Jetson™ board and a sensor f ...  Show more

Open-weight models are closing the gap with proprietary AI — and Timothée Lacroix, cofounder and CTO of Mistral, has been betting on that since day one. In this episode, he explains why open weights accelerate enterprise adoption, how Mistral is bringing model customization into ...  Show more

In this episode of the 2 Minute Medicine Podcast: AI Roundup, we examine how artificial intelligence is rapidly transitioning from research to real-world medical impact. We begin with Eli Lilly’s launch of TuneLab, a billion-dollar federated AI platform that opens the company’s r ...  Show more

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  Show more

The pulse of medical technology has quickened in recent years, bringing forth a new age in healthcare. Medical providers are working in partnership with artificial intelligence technology to reshape everything from patient diagnostics to treatment plans, operating with a precisio ...  Show more

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ...  Show more